Upcoming Medical Policies

Upcoming Medical Policies
BlueCross BlueShield of Tennessee

Each medical policy listed below will become effective on the date indicated, and will be included in the Medical Policy Manual for BlueCross BlueShield of Tennessee on that effective date.

Medical policies are developed using an evidence-based evaluation process. The medical evidence used in this process comes from several sources, including independent medical technology review organizations, the peer reviewed medical literature, and opinions from appropriate network specialists. All Medical Policies are reviewed by a panel of internal and external physicians before being adopted by the company.

Topics due to be included in the Medical Policy Manual on 12/12/2009

Topics due to be included in the Medical Policy Manual on 12/18/2009

Topics due to be included in the Medical Policy Manual on 1/9/2010

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Topics due to be included in the Medical Policy Manual on 12/12/2009:

Certolizumab Pegol

Degarelix Acetate

Dexamethasone Intravitreal Implant

Everolimus

Golimumab

In Vivo Analysis of Colorectal Polyps

Intravenous Immune Globulin (IVIG) Therapy